Andreas Weidemann
Overview
Explore the profile of Andreas Weidemann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
560
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wittig U, Weidemann A, Kania R, Peiss C, Rojas I
Comp Funct Genomics
. 2008 Jul;
5(2):156-62.
PMID: 18629066
Data quality in biological databases has become a topic of great discussion. To provide high quality data and to deal with the vast amount of biochemical data, annotators and curators...
12.
Weidemann A, Richter S, Stein M, Sahle S, Gauges R, Gabdoulline R, et al.
Bioinformatics
. 2008 May;
24(12):1463-4.
PMID: 18463116
Unlabelled: SYCAMORE is a browser-based application that facilitates construction, simulation and analysis of kinetic models in systems biology. Thus, it allows e.g. database supported modelling, basic model checking and the...
13.
Rojas I, Golebiewski M, Kania R, Krebs O, Mir S, Weidemann A, et al.
In Silico Biol
. 2007 Sep;
7(2 Suppl):S37-44.
PMID: 17822389
This paper briefly describes the SABIO-RK database model for the storage of reaction kinetics information and the guidelines followed within the SABIO-RK project to annotate the kinetic data. Such annotations...
14.
Eggert S, Paliga K, Soba P, Evin G, Masters C, Weidemann A, et al.
J Biol Chem
. 2004 Feb;
279(18):18146-56.
PMID: 14970212
Amyloid precursor protein (APP) processing is of major interest in Alzheimer's disease research, since sequential cleavages by beta- and gamma-secretase lead to the formation of the 4-kDa amyloid Abeta protein...
15.
Evin G, Weidemann A
Peptides
. 2002 Jul;
23(7):1285-97.
PMID: 12128085
Biochemical and genetic evidence indicates the balance of biogenesis/clearance of Abeta amyloid peptides is altered in Alzheimer's disease. Abeta is derived, by two sequential cleavages, from the receptor-like amyloid precursor...
16.
Evin G, Smith M, Tziotis A, McLean C, Canterford L, Sharples R, et al.
Neuroreport
. 2002 May;
13(6):917-21.
PMID: 11997713
We have analyzed the expression of Alzheimer's disease-associated presenilin 1 (PS1) in various neurodegenerative disorders. Western blotting identified PS1 N- and C-terminal fragments similarly in the cortex of controls, Parkinson,...
17.
Evin G, Smith M, Tziotis A, McLean C, Canterford L, Sharples R, et al.
Neuroreport
. 2002 Apr;
13(5):719-23.
PMID: 11973477
We have analyzed the expression of Alzheimer's disease-associated presenilin 1 (PS1) in various neurodegenerative disorders. Western blotting identified PS1 N- and C-terminal fragments similarly in the cortex of controls, Parkinson,...
18.
Weidemann A, Eggert S, Reinhard F, Vogel M, Paliga K, Baier G, et al.
Biochemistry
. 2002 Feb;
41(8):2825-35.
PMID: 11851430
Proteolytic processing of the transmembrane domain of the amyloid precursor protein (APP) is a key component of Alzheimer's disease pathogenesis. Using C-terminally tagged APP derivatives, we have identified by amino-terminal...